Abstract
Abstract
Background
Malignant hyperthermia (MH) is a rare, hereditary disease with a hypermetabolic response to volatile anesthetics/succinylcholine. Susceptible patients face difficulties due to a lack of knowledge about MH. As informational materials could increase knowledge and adherence to prevention/therapy, digital information about rare diseases validated for patients is needed. Our objective was to evaluate the following: (1) the impact of digital manuals on the knowledge/quality of life of MH patients and (2) access to MH services.
Materials and methods
Fifty MH-susceptible patients filled out a virtual questionnaire twice (demographic/economic/clinical data, MH knowledge and impact on daily life, and SF-36 quality of life). Test groups 1 (n = 17) and 2 (n = 16) were evaluated 30 and 180 days after receiving a digital manual, and the control group (n = 17; without manual) was evaluated after 180 days. We collected the MH service data about the number of contacts.
Results
Twenty-four (48%) patients reported problems in personal/professional life, sports, clinical/surgical/dental treatments, and military service, in addition to concerns about emergency care and complaints of sequelae. The percentage of correct answers in the second MH knowledge questionnaire increased for test group 2 (62% vs. 74.1%; unpaired t test, p < 0.01), was significantly greater in test groups 1 (68.1%) and 2 (74.1%) than in the control group (56.5%; Kruskal–Wallis, p < 0.05), and correlated with more time studying the manual and reports of MH-related problems (multiple regression, p < 0.05).
Conclusions
The digital manual improved patients’ MH knowledge. Online contacts with the MH service increased, allowing greater information dissemination. As informational materials could increase knowledge/adherence to prevention/therapy, digital information about MH validated for patients should be implemented.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference30 articles.
1. Rosenberg H, Sambuughin N, Riazi S, Dirksen R, Adam MP. Ardinger HH. et al. Malignant Hyperthermia Susceptibility. In: Adam MP, Ardinger HH, Pagon RA et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2020. www.ncbi.nlm.nih.gov/books/NBK1146/ [accessed 23 Oct 2020].
2. Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg. 2014;118:381–7. https://doi.org/10.1213/ANE.0b013e3182937d8b.
3. Litman RS, Griggs SM, Dowling JJ, Riazi S. Malignant hyperthermia susceptibility and related diseases. Anesthesiology. 2018;128:159–67. https://doi.org/10.1097/ALN.0000000000001877.
4. Clark NM, Becker MH, Janz NK, Lorig K, Rakowski W, Anderson LA. Self-Management of Chronic Disease by Older Adults. J Aging Health. 1991;3:3–27. https://doi.org/10.1177/089826439100300101.
5. Pauer F, Litzkendorf S, Göbel J, Storf H, Zeidler J, Schulenburg JMG. Rare Diseases on the Internet: An Assessment of the Quality of Online Information. J Med Internet Res. 2017;19:23. https://doi.org/10.2196/jmir.7056.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献